CANB - Canbiola, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0380
-0.0020 (-5.00%)
As of 11:06AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0400
Open0.0370
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0370 - 0.0400
52 Week Range0.0100 - 0.1350
Volume108,800
Avg. Volume1,507,141
Market Cap21.014M
Beta (3Y Monthly)-0.02
PE Ratio (TTM)N/A
EPS (TTM)-0.0170
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire14 days ago

    Canbiola Presentation from Annual Shareholder Meeting is Publicly Available

    Provides Details on Growth Strategy HICKSVILLE, NY, July 02, 2019 -- via NEWMEDIAWIRE -- Canbiola,Inc. (OTCQB: CANB)(“Canbiola” or the “Company”), a developer,.

  • GlobeNewswirelast month

    Canbiola and Shi Farms Execute Letter of Intent to Form Joint Venture for Hemp Cultivation & Processing

    Plans to Open a NY Depot for Hemp Cultivation HICKSVILLE, NY, June 12, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the.

  • GlobeNewswire2 months ago

    Canbiola Sets Annual Shareholder Meeting for Friday, June 14

    At Melville Marriott, Long Island Hotel from 10 am to 1 pm ET HICKSVILLE, NY, May 29, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the.

  • GlobeNewswire2 months ago

    Canbiola Announces First Quarter 2019 Results 

    Quarterly Revenue Increased 741% and Almost Matching Entire Year 2018; Revenue Maintained Gross Margin of 49% HICKSVILLE, NY, May 28, 2019 -- via NEWMEDIAWIRE.

  • Newsfile2 months ago

    Canbiola Announces First Quarter 2019 Results

    Quarterly Revenue Increased 741% and Almost Matching Entire Year 2018; Revenue Maintained Gross Margin of 49% Hicksville, New York--(Newsfile Corp. - May 28, 2019) - Canbiola, Inc. (OTCQB: CANB) ("Canbiola" or the "Company"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today operating and financial results for the first quarter ended March 31, 2019. "I am pleased ...

  • GlobeNewswire2 months ago

    Canbiola Appoints David Woycik, Jr. to its Corporate Advisory Board and Completes a 300% Increased Investment in its Duramed Division to Combat the Opioid Crisis

    Canbiola Chief Executive Officer, Marco Alfonsi, commented, “We are thrilled to have Mr. Woycik join our Corporate Advisory Board. Mr. David Woycik, Jr. stated, “I am extremely proud and honored to become a member of Canbiola’s Corporate Advisory Board. As the former Vice President and General Counsel of a major pharmaceutical company, PharmaFair, Inc., I fully appreciate the need for experienced and knowledgeable business men and women to assist this new and exciting company for greater success in the future.

  • ACCESSWIRE3 months ago

    Canadabis Capital Resumes Trading and Launches Corporate Website

    CALGARY, AB / ACCESSWIRE / April 30, 2019 / CanadaBis Capital Inc.("CanadaBis or the Company") is pleased to announce that it will begin trading as a Tier 2 Life Sciences Issuer on April 30th, 2019 under the symbol CANB and that it has officially launched its new corporate website, which is now available at www.canadabis.com. The new website will showcase the Company's products and services, as well as provide shareholders and potential investors a better understanding of CanadaBis's vision for the future. CanadaBis, through its subsidiaries, will operate the business of Stigma Grow and continue to be focused on producing high-quality and uniquely crafted products for the Alberta market.

  • CNW Group3 months ago

    IIROC Trading Resumption - CANB

    IIROC Trading Resumption - CANB

  • ACCESSWIRE3 months ago

    Uptick Newswire Hosts Canbiola, Inc. on the Stock Day Podcast to Discuss Their 500% Revenue Increase Since 2017

    PHOENIX, AZ / ACCESSWIRE / April 22, 2019 / Uptick Newswire Stock Day Podcast welcomed Canbiola, Inc. (CANB) ("the Company"), a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. CFO, Stan Teeple, joined Stock Day host Everett Jolly. Jolly began the interview by congratulating Teeple on the Company's substantial growth, which is reflected by their 500% revenue increase since 2017.

  • GlobeNewswire3 months ago

    Canbiola Announces Fourth Quarter and Full Year 2018 Results

    Annual Revenue Increased 445%, Maintained Gross Margin of 50% HICKSVILLE, NY, April 17, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the.

  • GlobeNewswire4 months ago

    Canbiola Appoints Additional Members to its Corporate Advisory Board

    HICKSVILLE, NY, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today the appointments of Mr. Jason Winn and Dr. Mehran Peter Ghazvini to its Corporate Advisory Board. Both have been active proponents for chronic pain management and tissue healing solutions. Canbiola Chief Executive Officer, Marco Alfonsi, commented, “We are pleased to have both Mr. Winn and Dr. Ghazvini join our Corporate Advisory Board.

  • ACCESSWIRE4 months ago

    Uptick Newswire Hosts Canbiola, Inc. on The Stock Day Podcast to Discuss Growth Potential in 2019

    PHOENIX, AZ / ACCESSWIRE / March 18, 2019 / Uptick Newswire Stock Day Podcast welcomed Canbiola, Inc.(CANB) (''the Company''), a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Executive Vice President of Domestic and International Sales, Andrew W. Holtmeyer, joined Stock Day host Everett Jolly.

  • GlobeNewswire4 months ago

    Marathon Group's Wholly Owned Subsidiary, MarathonRx, Secures 1st Large Order; 3 Product Lines Now Available

    WATERBURY, CT, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Marathon Group Corp. (PDPR) (the “Company” or “Marathon”) wholly owned subsidiary, MarathonRx, has signed their 1st order and expands product line to include previously mentioned 1,500mg Nano-Pure Ultra CBD Drops along with new products Tasty Drops 4 Pets and Muscle & Joint Salve. MarathonRx reviewed many companies to secure top quality products for their clients. Pure Health Product LLC, owned by Canbiola, Inc. (CANB), was chosen because they maintain a high level of quality throughout the manufacturing process, use organic ingredients wherever possible and/or naturally derived ingredients otherwise.

  • GlobeNewswire4 months ago

    Canbiola is Registered and Active in the GSA’s System for Award Management (SAM) and Department of Defense (DOD)

    HICKSVILLE, NY, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that it is now registered and active in the U.S. government GSA’s System for Award Management (SAM) and Department of Defense (DOD). The System for Award Management (SAM) is an official website of the U.S. government. GSA’s Office of Government-wide Policy is consolidating federal procurement and award systems into 1 new system—the System for Award Management (SAM).

  • Newsfile5 months ago

    Canbiola Finalizes Asset Purchase Agreement with Seven Chakras

    Attains Proprietary CBD Formulations Hicksville, New York--(Newsfile Corp. - February 28, 2019) - Canbiola, Inc. (OTCQB: CANB) ("Canbiola" or the "Company"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps and concentrate, announced today that its wholly owned subsidiary Pure Health Products (PHP) finalized its asset purchase agreement (APA) with Seven Chakras, LLC. Under the terms of this APA, which ...

  • GlobeNewswire5 months ago

    Canbiola Finalizes Asset Purchase Agreement with Seven Chakras.

    Attains Proprietary CBD Formulations HICKSVILLE, NY, Feb. 27, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer,.

  • Newsfile5 months ago

    Canbiola Deploys Initial 100 sam(R) Units and Readies Next 100 sam(R) Units

    Revolutionary CBD Wellness Solution for Tissue Healing and Chronic Pain is Now in the Hands of 100 Medical Professionals Hicksville, New York--(Newsfile Corp. - February 21, 2019) -  Canbiola, Inc. (OTCQB: CANB) ("Canbiola" or the "Company"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps and concentrate, announced today that its initial 100 Sustained Acoustic Medicine ("sam®") units have been deployed ...

  • GlobeNewswire5 months ago

    Canbiola Deploys Initial 100 sam® Units and Readies Next 100 sam® Units

    Revolutionary CBD Wellness Solution for Tissue Healing and Chronic Pain is Now in the Hands of 100 Medical Professionals HICKSVILLE, NY, Feb. 21, 2019 -- via NEWMEDIAWIRE.

  • GlobeNewswire5 months ago

    Canbiola to Exhibit at Integrative Healthcare Symposium and Engages Hayden IR to Launch Comprehensive Investor Relations Program

    Industry Tradeshow on February 21-23 at New York Hilton Midtown New York Focused on Increasing Awareness and Enhancing Shareholder Value HICKSVILLE, NY, Feb. 20, 2019 --.

  • GlobeNewswire5 months ago

    Canbiola Appoints NFL Great Leonard Marshall to its Sports Advisory Board

    HICKSVILLE, NY, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today the appointment of Leonard Marshall to its Sports Advisory Board. Canbiola Chief Executive Officer Marco Alfonsi commented, “We are honored and thrilled to have partnered with Leonard Marshall to help increase the awareness of the benefits of CBD and our Canbiola products. Leonard Marshall stated, “I am proud to partner with Canbiola and endorse their CBD products and solutions to the market.

  • GlobeNewswire5 months ago

    Stephen Medina Joins Canbiola, Inc. Corporate Advisory Board

    HICKSVILLE, NY, Feb. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB), is pleased to announce that Steven Medina Esq. Mr. Medina is a well-recognized and seasoned healthcare professional in corporate compliance.  His specific knowledge of the Medicare, Medicaid and HIPAA regulatory environment makes him uniquely qualified to provide infrastructure and support in such key and critical areas as operations, revenue cycle, management, and ancillary provider contracts.  Professionally Mr. Medina brings his expertise into service to oversee and monitor healthcare compliance program implementation, developing, coordinating and participation in compliance training program that focuses on the essential elements of the medical field compliance programs. Mr. Medina has held training programs for both employees and physicians to better understand and comply with pertinent federal and state statues as well as regulations and standards.  Mr. Medina is often called upon to review and revise corporate compliance programs in light of changes in the needs of the practice or changes in the law.

  • GlobeNewswire5 months ago

    Canbiola Launches Revolutionary CBD Wellness Solution for Tissue Healing and Chronic Pain Expected to Accelerate Revenue Growth in 2019 and Commits to 1,650 SAM Units in 2019 with Each Potentially Generating $14,210 Revenue Per Year

    HICKSVILLE, NY, Jan. 31, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of.

  • GlobeNewswire5 months ago

    Uptick Newswire Hosts Canbiola Inc. on the Stock Day Podcast to Discuss its Recent Acquisition of HudiLab Inc. and Share Their Expectations for the Future

    Uptick Newswire Stock Day Podcast welcomed Canbiola Inc. (CANB), a US company embarking in the sale of a variety of Cannabidiol (CBD) based products, to discuss their recent acquisition of HudiLab Inc. and the advantages of their wholly owned subsidiary, DuraMed Inc. CFO, Stan Teeple, joined Stock Day host Everett Jolly.

  • GlobeNewswire6 months ago

    Canbiola, Inc. (OTCQB: CANB) Announces the Formation of a New Wholly Owned Subsidiary- DuraMed, Inc.

    HICKSVILLE, NY, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (CANB) announces the formation of a new wholly owned subsidiary- DuraMed, Inc. In an effort to expand its product offering within the medical and wellness segments of the CBD industry, Canbiola has launched DuraMed, Inc., as a wholly owned subsidiary.  DuraMed is a medical device company that provides equipment and services to both medical offices as well as direct to consumer.  All DuraMed products will be FDA approved, non-invasive, consumer-friendly, and will focus upon aiding in quicker injury recovery as well as pain relief.

  • GlobeNewswire6 months ago

    Senator Ronald A. Silver Joins Canbiola, Inc. Corporate Advisory Board

    HICKSVILLE, NY, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB), is pleased to announce that Senator Ronald A. Silver has joined its Corporate Advisory Board.  The purpose of the Advisory Board is to assist and advise the Board of Directors and Executive team’s effort in growing Canbiola fiscally and in a socially responsible manner and the Company welcomes a man with extensive legislative and regulatory experience. Senator Ronald A. Silver was first elected to the Florida House of Representatives in 1978 and continued his tenure in that body until 1992.